CatalystAlert

Search CatalystAlert

Search for companies, drugs, and catalysts

Search CatalystAlert

Search for companies, drugs, and catalysts

Cancer Network
Original article

<![CDATA[Pirtobrutinib Earns Approval in China for CLL/SLL Across All Therapy Lines]]>

CLL-313CLL-314Pirtobrutinib

Read the original article

Published by Cancer Network on September 28, 2026 2:30 PM

Read Original